Safety Profile and Effectiveness of Rivaroxaban for Patients With Venous Thromboembolism in Japan ― Results From Post-Marketing Surveillance (XASSENT) ―Ikuo Fukuda, Takanori Hayasaki, Atsushi Hirayama et al.|Circulation Journal|2023Cited by 3
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)Ikuo Fukuda, Takanori Hayasaki, Atsushi Hirayama et al.|TH Open|2021Cited by 2
PE-269 CC Chemokine Receptor-2 Deficiency Attenuates Oxidative Stress and Infarct Size Caused by Myocardial Ischemia-reperfusion in Mice(Myocardial ischemia-reperfusion, basic/clinical-4 (IHD) PE45,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)Takanori Hayasaki, Motohiro Takeya, Eiichiro Yamamoto et al.|Japanese Circulation Journal-english Edition|2006Cited by 1